Nonoxynol-9 gonorrhea/chlamydia prevention substantiated, joint cmte. says.
This article was originally published in The Tan Sheet
Executive Summary
NONOXYNOL-9 SAFETY, EFFICACY AS GONORRHEA/CHLAMYDIA PROPHYLACTIC SUPPORTED by existing clinical data, FDA's Non-prescription Drugs, Reproductive Health Drugs, Anti-Infective Drugs and Antiviral Drugs Advisory Committees agreed at a Nov. 20-22 joint meeting in Gaithersburg, Md. In their discussion of whether the topical vaginal spermicide is proven to provide prophylaxis from the sexually transmitted diseases gonorrhea and chlamydia, committee members voted 18-1 that N-9 is effective and 11-8 that the ingredient is safe. The group felt that five of the six studies that make up the bulk of the evidence are adequate and one is "excellent."